XML 81 R71.htm IDEA: XBRL DOCUMENT v3.20.2
STOCKHOLDERS' EQUITY (Schedule of Stock Option Activity) (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Dec. 31, 2019
USD ($)
$ / shares
shares
Number of Shares    
Outstanding, beginning balance (in shares) | shares 6,210,385  
Granted (in shares) | shares 146,500  
Exercised (in shares) | shares (285,388)  
Canceled (in shares) | shares (182,616)  
Outstanding, ending balance (in shares) | shares 5,888,881 6,210,385
Options vested and exercisable (in shares) | shares 5,199,107  
Weighted-Average Exercise Price    
Outstanding, beginning balance (in USD per share) | $ / shares $ 25.10  
Granted (in USD per share) | $ / shares 31.42  
Exercised (in USD per share) | $ / shares 12.64  
Canceled (in USD per share) | $ / shares 47.34  
Outstanding, ending balance (in USD per share) | $ / shares 25.17 $ 25.10
Options vested and exercisable (in USD per share) | $ / shares $ 23.63  
Weighted- Average Remaining Contractual Term    
Outstanding, Weighted-Average Remaining Contractual Term (in years) 3 years 10 months 24 days 4 years 3 months 18 days
Options vested and exercisable, Weighted-Average Remaining Contractual Term (in years) 3 years 4 months 24 days  
Aggregate Intrinsic Value    
Outstanding, Aggregate Intrinsic Value | $ $ 21,260 $ 75,805
Options vested and exercisable, Aggregate Intrinsic Value | $ $ 21,260